UK approves Eli Lilly's weight-loss pill; EU access lags
The UK's medicines regulator has approved Eli Lilly's oral weight-loss drug Foundayo, marking the first European license for the medication. Access in the EU is not expected until next year, while a decision on NHS coverage in the UK is due in November.











